Trials / Recruiting
RecruitingNCT07366138
Ultrasound-Guided External Oblique Intercostal Plane Block Versus Subcostal Transversus Abdominis Plane Block For Perioperative Analgesia in Laparoscopic Sleeve Gastrectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the analgesic efficacy, duration of analgesia, and overall opioid consumption between the external oblique intercostal plane (EOIP) block and subcostal transversus abdominis plane (TAP) block in patients undergoing laparoscopic sleeve gastrectomy.
Detailed description
Postoperative pain management is a critical aspect of enhanced recovery after surgery (ERAS) protocols, particularly in laparoscopic bariatric procedures such as sleeve gastrectomy. Among the ultrasound-guided abdominal wall blocks, the transversus abdominis plane (TAP) block and its subcostal variant have demonstrated efficacy for upper abdominal surgeries. The subcostal TAP block provides analgesia for the T6-T9 dermatomes, covering incisions in upper abdominal procedures like laparoscopic cholecystectomy and bariatric surgery. The external oblique intercostal plane (EOIP) block is a relatively new fascial plane block that targets the intercostal nerves lying between the external oblique and intercostal muscles.
Conditions
- Ultrasound
- External Oblique Intercostal Plane Block
- Subcostal Transversus Abdominis Plane Block
- Perioperative Analgesia
- Laparoscopic Sleeve Gastrectomy
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | External oblique intercostal plane block | Patients will receive an ultrasound-guided bilateral external oblique intercostal plane (EOIP) block using 20 mL of 0.25% bupivacaine in each side after induction of anesthesia and prior to surgical incision. |
| OTHER | Subcostal transversus abdominis plane block | Patients will receive a bilateral subcostal transversus abdominis plane (TAP) block using 20 mL of 0.25% bupivacaine in each side, under ultrasound guidance and identical conditions. |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2026-01-26
- Last updated
- 2026-01-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07366138. Inclusion in this directory is not an endorsement.